S Weiss, E Enwere, L Andersen… - US Patent …, 2011 - freepatentsonline.com The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which ... Cached
KO Yariz, T Walsh, A Uzak, M Spiliopoulos… - Fertility and Sterility, 2011 - Elsevier ... Case report. Inherited mutation of the luteinizinghormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. ... Key Words: Empty follicle syndrome; luteinizing hormone/choriogonadotropin receptor; infertility; next-generation sequencing. ... Related articles - All 3 versions
[HTML] from nih.govCL Newton, AM Whay, CA McArdle… - Proceedings of the …, 2011 - National Acad Sciences Naturally occurring mutations of G protein-coupled receptors (GPCRs) causing misfolding and failure to traffic to the cell surface can result in disease states. Some small-molecule orthosteric ligands can rescue such misfolded receptors, presumably by facilitating their correct ... Related articles - All 4 versions
JM Blumberg, EO Kwon, TC Cheetham, F Niu… - Urology, 2011 - Elsevier A total of 692 patients who received an LHRH agonist as primary monotherapy for prostate cancer fit our criteria. Calendar-based dosing was used in 325 patients; 252 received T-based dosing and 115 received intermittent dosing. On multivariate analysis controlling for ... Cited by 1 - Related articles - All 6 versions
JS Redmond, GM Baez‐Sandoval… - Journal of …, 2011 - Wiley Online Library This is an Accepted Article that has been peer-reviewed and approved for publication in the Journal of Neuroendocrinology, but has yet to undergo copy-editing and proof correction. Please cite this article as an “Accepted Article”; doi: 10.1111/j.1365-2826.2011.02177.x Related articles